Johnson & Johnson traded at $182.29 this Friday June 24th, increasing $2.63 or 1.46 percent since the previous trading session. Looking back, over the last four weeks, J&J gained 1.49 percent. Over the last 12 months, its price rose by 11.01 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 177.39 by the end of this quarter and at 163.45 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
182.29
Daily Change
1.46%
Yearly
11.01%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 152.34 2.89 1.93% 34.84%
Abiomed 255.32 6.70 2.69% -18.05%
Abbott 109.45 3.24 3.05% -2.90%
Amgen 245.37 2.28 0.94% 1.11%
AstraZeneca 10,776.00 396.00 3.82% 26.79%
Astrazeneca 66.90 2.45 3.80% 12.72%
Baxter International 66.78 1.70 2.61% -18.75%
Bayer 57.79 -0.75 -1.28% 11.59%
Becton, Dickinson and Co. 250.92 8.38 3.46% 4.03%
Biogen 211.93 0.55 0.26% -39.09%
Bristol-Myers Squibb 78.96 1.27 1.63% 18.31%
Boston Scientific 38.02 1.08 2.92% -13.79%
CONMED 94.07 2.83 3.10% -33.28%
Cooper Companies 323.49 15.78 5.13% -18.40%
Cardiovascular Systems 14.97 0.38 2.60% -66.00%
Dexcom 77.67 2.46 3.27% -81.95%
Edwards Lifesciences 96.98 3.36 3.59% -6.36%
Gilead Sciences 63.08 0.50 0.80% -7.07%
Globus Medical 57.85 1.10 1.94% -25.32%
GlaxoSmithKline 1,756.20 36.60 2.13% 24.27%
Hologic 70.93 0.38 0.54% 7.65%
Integra LifeSciences 54.49 0.59 1.09% -22.20%
Intuitive Surgical 209.67 5.17 2.53% -76.92%
J&J 182.29 2.63 1.46% 11.01%
Eli Lilly 325.62 12.90 4.13% 41.44%
Medtronic 90.22 1.55 1.75% -27.78%
Merit Medical Systems 52.94 -0.54 -1.01% -17.86%
Merck & Co 93.13 1.13 1.23% 20.63%
Novartis 80.60 2.37 3.03% -4.80%
NuVasive 50.67 0.48 0.96% -27.50%
Pfizer 51.59 1.50 2.99% 32.35%
Insulet 227.73 8.76 4.00% -18.18%
Regeneron Pharmaceuticals 612.49 5.10 0.84% 11.25%
Roche Holding 318.80 12.50 4.08% -7.54%
Sanofi 100.56 4.81 5.02% 13.95%
Stryker 204.43 4.37 2.18% -22.27%
Teva Pharmaceutical Industries Ltd 2,689.00 12.00 0.45% -20.84%
Tandem Diabetes Care 61.52 2.79 4.75% -38.08%
Vertex Pharmaceuticals 292.55 9.05 3.19% 50.54%
Zimmer Biomet Holdings Inc 108.87 2.47 2.32% -34.36%
Zoetis 174.61 5.44 3.22% -6.74%

Indexes Price Day Year
US500 3925 116.01 3.06% -8.52%
US30 31532 823.32 2.68% -8.03%

J&J
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.